Skip to main content

신동엽 교수

Dong-Yeop Shin

서울대학교 내과 · 의학

연구실 소개

신동엽 교수의 연구실은 백혈병과 림프종을 포함한 혈액세포종양의 발병 기전과 치료 전략을 연구하는 데 초점을 맞추고 있습니다. 특히 TP53 유전자 변이가 유발하는 종양 생물학적 복잡성과 급성 백혈병의 유전자-대사 연관성, T세포 발달의 생리적 조건을 모사하는 세포 배양 시스템 개발을 통해 신뢰도 높은 혈액세포 치료 기반 기초 연구를 수행하고 있습니다. 또한 다발성 카스팅먼병과 심장 림프종 등 희귀 혈액질환의 예후 인자 및 치료 전략에 대한 임상적 분석도 함께 진행하고 있습니다.

유전자 변이대사 프로파일백혈병 스템세포T세포 발달희귀 혈액질환

연구 현황

논문 수
308
총 인용 수
2,834
최근 5년 논문
136
주요 분야
의학

연구 성과 추이

표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수
136총합
2021
2022
2023
2024
2025
5개년 연도별 피인용 수
585총합
20212022202320242025

주요 논문

15
1
논문|인용수 318·2014
EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Dong‐Yeop Shin, Im Il Na, Cheol Hyeon Kim, Sunhoo Park, HeeJong Baek, Sung Hyun Yang
SJR Q1Journal of Thoracic OncologyOA
Pulmonary and Respiratory MedicineMedicine
2
리뷰|인용수 39·2023
TP53 Mutation in Acute Myeloid Leukemia: An Old Foe Revisited
Dong‐Yeop Shin
SJR Q1CancersOA

Introduction: TP53 is the most commonly mutated gene in human cancers and was the first tumor suppressor gene to be discovered in the history of medical science. Mutations in the TP53 gene occur at various genetic locations and exhibit significant heterogeneity among patients. Mutations occurring primarily within the DNA-binding domain of TP53 result in the loss of the p53 protein’s DNA-binding capability. However, a complex phenotypic landscape often combines gain-of-function, dominant negative

HematologyMedicine
3
논문|인용수 39·2011
Clinical dissection of multicentric Castleman disease
Dong‐Yeop Shin, Yoon Kyung Jeon, Yong-Sang Hong, Tae Min Kim, Se‐Hoon Lee, Dong-Wan Kim, Inho Kim, Sung‐Soo Yoon, Dae Seog Heo, Seonyang Park, Byoung Kook Kim
SJR Q2Leukemia & lymphoma/Leukemia and lymphoma

This study investigated the prognostic factors of Castleman disease (CD) and focused specifically on multicentric CD (MCD). Seventy patients with CD were studied. Forty-three patients (61.5%) had unicentric CD (UCD) and 27 patients (38.5%) had MCD. Thirty-six patients with UCD (83.7%) underwent surgical excision, and 25 patients with MCD (92.6%) received systemic treatment, including corticosteroids and combination chemotherapy. In the patients with MCD, age >60 years and the presence of splenom

OncologyMedicine
4
논문|인용수 35·2017
Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials
Koung Jin Suh, Ji Yun Lee, Dong‐Yeop Shin, Youngil Koh, Soo‐Mee Bang, Sung‐Soo Yoon, Seonyang Park, Inho Kim, Jeong‐Ok Lee, Jeong‐Ok Lee, Jeong‐Ok Lee
SJR Q2International Journal of Hematology
HematologyMedicine
5
논문|인용수 32·2015
Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma
Dong-Yeop Shin, Areumnuri Kim, Hye Jin Kang, Sunhoo Park, Dong Wan Kim, Seung‐Sook Lee
SJR Q1Cancer Letters
OncologyMedicine
6
논문|인용수 18·2012
Toxicities and functional consequences of systemic chemotherapy in elderly Korean patients with cancer: A prospective cohort study using Comprehensive Geriatric Assessment
Dong‐Yeop Shin, Jeong‐Ok Lee, Yu Jung Kim, Myung‐Sook Park, Keun‐Wook Lee, Kwang‐Il Kim, Soo‐Mee Bang, Jong Seok Lee, Cheol‐Ho Kim, Jee Hyun Kim
SJR Q1Journal of Geriatric Oncology
Geriatrics and GerontologyMedicine
7
논문|인용수 17·2020
Physioxia enhances T-cell development ex vivo from human hematopoietic stem and progenitor cells
Dong‐Yeop Shin, Xinxin Huang, Chang-Hyun Gil, Arafat Aljoufi, James Ropa, Hal E. Broxmeyer
SJR Q1Stem CellsOA

Abstract Understanding physiologic T-cell development from hematopoietic stem (HSCs) and progenitor cells (HPCs) is essential for development of improved hematopoietic cell transplantation (HCT) and emerging T-cell therapies. Factors in the thymic niche, including Notch 1 receptor ligand, guide HSCs and HPCs through T-cell development in vitro. We report that physiologically relevant oxygen concentration (5% O2, physioxia), an important environmental thymic factor, promotes differentiation of co

HematologyMedicine
8
논문|인용수 17·2015
Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP
Dong‐Yeop Shin, Areumnuri Kim, Byung Hyun Byun, Hansol Moon, Soyeun Kim, Young-Jin Ko, Min‐Jung Kim, Hyo‐Rak Lee, Hye‐Jin Kang, Im Il Na, Sunhoo Park, Seung‐Sook Lee
SJR Q2Annals of Hematology
Pathology and Forensic MedicineMedicine
9
리뷰|인용수 13·2022
Human acute myeloid leukemia stem cells: evolution of concept
Dong‐Yeop Shin
SJR Q2Blood ResearchOA

The history of human acute myeloid leukemia stem cells (AMLSCs) began in a seminal study performed by Lapidot and Dick, proving that only CD34+CD38- human primary acute myeloid leukemia (AML) cells can repopulate in severe combined immunodeficient mice. The concept of leukemic stem cells (LSCs) has impeded a huge change in the treatment strategy against AML from killing proliferating leukemic cells to eradicating quiescent/dormant LSCs. As next-generation sequencing technologies have developed,

HematologyMedicine
10
논문|인용수 12·2010
Long-term disease-free survival of patients with primary cardiac lymphoma treated with systemic chemotherapy and radiotherapy
Dong‐Yeop Shin, Yun‐Gyoo Lee, Hyun-Jung Lee, Seyoun Choi, Jin Joo Park, Dong-Wan Kim
The Korean Journal of HematologyOA

Primary cardiac lymphoma (PCL) is a rare disease entity with only a few reported cases in Korea. In this paper, we report a case of PCL in a 59-year-old man presenting with chest pain. Diffuse large B-cell lymphoma was diagnosed through a cardiac catheterization-assisted percutaneous endomyocardial biopsy, and there was no evidence of extracardiac involvement of the lymphoma.The patient had a complete clinical response after systemic chemotherapy with a rituximab, cyclophosphamide, doxorubicin,

Cardiology and Cardiovascular MedicineMedicine
11
논문|인용수 11·2016
Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma
Dong‐Yeop Shin, Byung Hyun Byun, Kyeong Min Kim, Joo Hyun Kang, Ilhan Lim, Byung Il Kim, Seung‐Sook Lee, Chang Woon Choi, Hye Jin Kang, Sang Moo Lim
SJR Q1Cancer Chemotherapy and Pharmacology
Pathology and Forensic MedicineMedicine
12
논문|인용수 10·2016
Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis
Dong‐Yeop Shin, Seok Jin Kim, Dok Hyun Yoon, Yong Park, Jee Hyun Kong, Jeong‐A Kim, Byung-Su Kim, Hyo Jung Kim, Jong-Ho Won, Sung-Kyu Park, Won Seog Kim
SJR Q1Cancer Chemotherapy and Pharmacology
Pathology and Forensic MedicineMedicine
13
letter|인용수 9·2022
The importance of critically short telomere in myelodysplastic syndrome
Dong‐Yeop Shin, Kyu Min Lim, Hee Sue Park, Sunghoon Kwon, Sung‐Soo Yoon, Dong-Soon Lee
SJR Q1Biomarker ResearchOA

A few critically short telomeres trigger genomic instability regardless of average telomere length (TL). Recently, the telomere shortest length assay (TeSLA) was developed to detect critically short telomeres and measure absolute telomeres. Using TeSLA with the internally labeled biotin probe, we measured the TL of bone marrow (BM) aspirates from 52 patients with myelodysplastic syndrome (MDS). A percentage of shortest telomeres (< 1.0 kb (ShTL1.0)) were calculated. ShTL1.0 was correlated to IPS

PhysiologyMedicine
14
논문|인용수 9·2022
Expansion of Human Megakaryocyte-Lineage Progeny via Aryl Hydrocarbon Receptor Antagonism with CH223191
Dongchan Kim, Dong‐Yeop Shin, Jun Liu, Na-rae Jeong, Youngil Koh, Junshik Hong, Xinxin Huang, Hal E. Broxmeyer, Sung-Soo Yoon
SJR Q2Stem Cell Reviews and Reports
HematologyMedicine
15
논문|인용수 9·2014
Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinoma
Dong‐Yeop Shin, S. Kim, Sohee Park, Jae-Soo Koh, C. H. Kim, HeeJong Baek, Sheng Yang, I. I. Na
SJR Q1Endocrine Related CancerOA

There have been several epidemiological studies of the association between 25-hydroxyvitamin D (25(OH)D) level and lung cancer risk. We explored the potential association between serum 25(OH)D levels and mutations in epidermal growth factor receptor (EGFR) in patients with pulmonary adenocarcinoma. We analyzed clinical data from 135 patients whose serum 25(OH)D levels were measured and EGFR mutational status was tested at the time of diagnosis. The relationship between 25(OH)D and clinical facto

Pathology and Forensic MedicineMedicine

대표 연구 분야

HematologyPathology and Forensic MedicineOncologyGeneticsMolecular BiologyPulmonary and Respiratory Medicine

신동엽 교수의 연구를 Nubint에서 더 깊이 살펴보세요

이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.